Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Avai Bio (AVAI) Shares Outstanding (Weighted Average) (2018 - 2023)

Avai Bio's Shares Outstanding (Weighted Average) history spans 3 years, with the latest figure at $74.8 million for Q4 2023.

  • For Q4 2023, Shares Outstanding (Weighted Average) rose 132.2% year-over-year to $74.8 million; the TTM value through Dec 2023 reached $74.8 million, up 132.2%, while the annual FY2023 figure was $38.5 million, N/A changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2023 was $74.8 million at Avai Bio, up from $74.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $74.8 million in Q4 2023 and bottomed at $1.0 million in Q1 2020.
  • The 3-year median for Shares Outstanding (Weighted Average) is $32.2 million (2022), against an average of $37.8 million.
  • The largest YoY upside for Shares Outstanding (Weighted Average) was 132.2% in 2023 against a maximum downside of 119.05% in 2023.
  • A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $26.3 million in 2020, then grew by 22.64% to $32.2 million in 2022, then skyrocketed by 132.2% to $74.8 million in 2023.
  • Per Business Quant, the three most recent readings for AVAI's Shares Outstanding (Weighted Average) are $74.8 million (Q4 2023), $74.3 million (Q3 2023), and $57.6 million (Q2 2023).